Clinical Trial Update: PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

View source ↗

Summary

Pfizer-sponsored completed trial evaluating the effectiveness of PCV13 against vaccine-type pneumococcal hospitalised community-acquired pneumonia in adults age…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Community Acquired Pneumonia (CAP) | Status: COMPLETED | Results posted: 2025-01-27